Malaysian Genomics Resource Centre Berhad Supports Yayasan Seri Negara’s Ramadhan Initiative
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to support Yayasan Seri Negara's (YSN) Ihya Ramadhan...
SinoMab Announces IND APPLICATION FOR SN1011 APPROVED BY NMPA
SinoMab BioScience Limited (SinoMab or the Company, together with its subsidiaries, the Group, HKG: 3681), a Hong Kong-based biopharmaceutical company dedicated to the research,...
Actual net profit exceeds FY2020’s level, China Biotech Services’ (08037) new growth drivers expected...
As the pandemic continued to affect the market, China Biotech Services (HKG: 8037), which owns one of the largest nucleic acid testing laboratories in...
EC Healthcare expects sales volume to increase 35% Y-o-Y to no less than HK$3...
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital medical group in Hong...
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its CRO services to the US, is pleased to sponsor the Pre-ASCO...
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting...
Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the news that its client XWPharma Ltd. has announced dosing...
Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox
The company is raising USD$25 million from investors in Australia, Asia and USA. Topelia Australia, a biotech company established to commercialise a novel ATT treatment...
Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing...
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials...
Novotech Acquires US CRO NCGS, Expands Global Expertise
Novotech, the leading Asia-Pacific biotech specialist CRO, has acquired US CRO NCGS as part of its expansion program, and can now offer its biotech...
Legend Capital’s Portfolio Company Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis
Legend Capital's portfolio company Xbiome Inc., an industry-leading and AI-driven microbiome therapeutics company, recently announced that it acquired the clinical-stage M201 program from Assembly...
EC Healthcare Opens New Multi-Service Flagship Medical Centre at Central and Advanced Imaging Centre...
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group...
Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 – Best Contract Research Organization...
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for the Best Contract Research...
MBMV invests in international bio-tech startup Arcensus GmbH
Based on Whole Genome Sequencing (WGS), Arcensus GmbH makes it possible to detect rare as well as frequent disorders such as cancer or heart...
Bintai Kinden Corporation Berhad Emerges as Substantial Shareholder in Malaysian Genomics Resource Centre Berhad
Malaysian Genomics Resource Centre Berhad ("MGRC" or "the Group"), a leading genomics and biopharmaceutical specialist, is pleased to announce the entry of a new...
GFI APAC announces the “2020 Asia Alt 100” Industry Disruptors in Alternative Protein
Significant opportunities identified in growing and processing raw materials in Asia The Good Food Institute Asia-Pacific (GFI APAC) today reveals the "2020 Asia Alt 100" organizations,...
Malaysian Genomics Resource Centre Berhad Awarded Covid-19 Surveillance Contract
Malaysian Genomics Resource Centre Berhad ("Malaysian Genomics" or "the Group"), a leading genomics and biopharmaceutical specialist, was recently awarded a COVID-19 surveillance contract by...
BBGI PCL (SET: BBGI) Debuts Shares on the SET March 17
Aiming to be a leading bio-product group with green innovation and sustainability BBGI PCL (SET: BBGI), a leader in the biofuel energy industry and...
Avance Clinical Announces New Office Opening in Sydney
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Sydney to support its growing clinical...
Phase I Clinical Trial of AIM mRNA COVID-19 Vaccine (LVRNA009) Won the Praise of...
On January 8, AIM Vaccine held a meeting at Shulan (Hangzhou) Hospital to report on the analysis results of the phase I clinical trial...
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded its gene technology clinical...